Michiyuki Yamada

Title: Michiyuki Yamada: Innovator in Anti-PAD4 Antibody Research

Introduction

Michiyuki Yamada is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of medical research, particularly in the development of anti-PAD4 antibodies. With a total of 2 patents, his work focuses on innovative treatments for rheumatoid arthritis (RA).

Latest Patents

Yamada's latest patents revolve around anti-PAD4 antibodies that exhibit excellent properties for treating RA. These antibodies specifically bind to an epitope containing positions 345, 347, and 348 of PAD4. They are designed to inhibit the citrullination activity of PAD4, which is crucial in the pathology of RA. Furthermore, these anti-PAD4 antibodies may have a KD (M) of 9.0×10 or less. In some cases, the anti-PAD4 antibody is used in combination with a TNFα inhibitor to enhance treatment efficacy.

Career Highlights

Throughout his career, Michiyuki Yamada has been associated with esteemed institutions such as the Public University Corporation Yokohama City University and the Public University Corporation Nagoya City University. His work has been instrumental in advancing the understanding and treatment of autoimmune diseases.

Collaborations

Yamada has collaborated with notable colleagues, including Mamoru Sato and Satoshi Kanazawa. These partnerships have contributed to the success of his research and the development of innovative therapeutic solutions.

Conclusion

In summary, Michiyuki Yamada is a distinguished inventor whose work on anti-PAD4 antibodies has the potential to transform the treatment landscape for rheumatoid arthritis. His contributions to medical research continue to pave the way for future innovations in this critical area.